Selected 2003 Licensing and Technology Transactions

Selected 2003 Licensing and Technology Transactions

Publication

Related Documents

Related Solutions

We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.
For companies in the life sciences sphere, licensing intellectual property and establishing strategic alliances are critical. WilmerHale’s experienced licensing lawyers shepherd biotech, pharmaceutical, healthcare and medical device clients of all sizes through the complex transactions that make their businesses possible, including a broad range of licensing, collaboration, strategic alliance and joint venture agreements. Our attorneys also excel at brokering manufacturing and supply agreements, contract research and development agreements, distribution and commercialization services agreements, and material transfer and confidentiality agreements. They also frequently represent life sciences clients as they license patents—often the foundations of their companies—from, and sponsor research at, leading academic institutions across the United States and Europe. Backed not only by their own experience but also the deep well of knowledge possessed by the firm’s patent, tax, antitrust and EU competition lawyers, our transactional attorneys are ready to handle even the most multifaceted matters. Our team helps clients protect their innovations, forge strategic alliances, and successfully navigate a complex, dynamic industry.
Our clients in the ever-changing and fiercely competitive hardware, software, IT and services industries depend on us to strategize and negotiate transactions that take advantage of opportunities now while protecting their innovations and preserving flexibility for the future. We structure, negotiate and draft all types of licensing, distribution, product development, joint venture and strategic alliance agreements for these clients, often drawing on the deep experience of WilmerHale’s unique capabilities in regulatory, intellectual property, corporate and tax law. We represent both mature and emerging companies with business models centered around offering software and/or professional services relating to analyzing and extracting insights from large data sets. We frequently draft and negotiate data license agreements, software-as-a-service (SaaS) agreements, website terms and other services agreements in which data is the core subject of the license. We also advise technology clients on big data issues that arise in outsourcing, joint venture and other transactional matters. Our attorneys keep a close watch on internet-related legislative and regulatory developments in the United States, the European Union and elsewhere, and leverage our up-to-the-minute knowledge to advise clients in areas such as data privacy and security, copyright infringement, and export restrictions.

In 2003, we handled hundreds of licensing, product development, distribution, joint venture, strategic alliance, collaboration and similar agreements for clients. The following are selected highlights from our 2003 transactions:

  • 170 Systems — Licensing of ERP business process automation applications
  • American Superconductor — Distribution, licensing and product development agreements
  • Analog Devices — Product development, supply, OEM, license and outsourcing agreements
  • Biogen Idec — Collaboration with Genentech for the joint research and development of a Biogen protein therapeutic
  • BOSE — Agreements for international distribution of premier sound systems
  • CCBN — License and distribution agreements for investor relations solutions and investment information
  • Critical Therapeutics — Alliance with MedImmune to co-develop biologic products to treat severe inflammatory diseases
  • Curis — Cancer therapeutic collaboration with Genentech
  • Eyetech Pharmaceuticals — Collaboration agreement with Pfizer to jointly develop and commercialize ophthalmic products for the treatment of blindness
  • Eclipsys Corporation — Integration of eOptimize's scheduling solution into Eclipsys's healthcare management software suite
  • Flexplay — License of limited-play DVD technology to Disney
  • Genaissance Pharmaceuticals — Collaboration with Bayer HealthCare to identify pharmacogenomic markers of drug safety and efficacy
  • GenPath Pharmaceuticals, Inc. — Collaboration agreement with Merck to identify targets for the development of small molecule oncology agents
  • Ixos — Strategic alliances with Hitachi Data Systems and StorageTek
  • Idenix Pharmaceuticals — Collaboration agreement with Novartis to jointly develop and commercialize Idenix’s core antiviral drug candidates
  • IETF — Intellectual property advice for the leading Internet standards body
  • IGEN — License of electrochemiluminescence technologies to Roche Diagnostics
  • Infinity Pharmaceuticals — Collaboration and license agreement to provide Amgen with access to Infinity's proprietary small molecules for drug development
  • Infineon Technologies — Advice on US aspects of complex IT agreements
  • Lifeline — Distribution agreement with Home Technology Systems
  • MapInfo — Exclusive license to Marconi Vertical Mapper product line
  • Mentor Graphics — Advice on international software licensing transactions
  • Millennium — Agreement with Ortho Biotech to collaborate on the commercialization and continued clinical development of VELCADE cancer therapy
  • NFL™ — Television rights agreements with various international broadcasters
  • NHL — Advice on various digital broadcast issues
  • Novartis — IP asset sale and cross license with Cell Genesys as part of global alliance
  • Omrix Biopharmaceuticals — Distribution and supply agreement with Johnson & Johnson Wound Management for Quixil fibrin sealant product
  • Public Interest Registry — Advice to .org Internet domain registry
  • SmartBargains — Agreements with online merchants for B2C shopping portal
  • Starent Networks — Product supply and OEM agreements with major U.S. and European telecom companies
  • Syngenta — Exclusive license of Torrey Mesa Research Institute IP to Diversa
  • TargetRx — Marketing information engagements by major pharmaceutical companies
  • The Dun & Bradstreet Corporation — Master service agreements for risk management and sales and marketing solutions
  • The Medicines Company — Feasibility, development and commercial supply agreement
  • The SNP Consortium Ltd. — Participation in international HapMap project
  • TKT Transkaryotic Therapies — Collaboration with Genzyme to develop and commercialize enzyme replacement therapy to treat Hunter syndrome in Asia
  • WaterCove Networks — Strategic OEM agreement with Alcatel for mobile data services
  • Wyeth — Licensing advice on key biotechnology collaborations

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel